CRISPR/Cas9 therapy can suppress aging, enhance health and extend life span in mice
Researchers have developed a new gene therapy to help decelerate the aging process. The findings highlight a novel CRISPR/Cas9 genome-editing therapy that can suppress the accelerated aging observed in mice with Hutchinson-Gilford progeria syndrome, a rare genetic disorder that also afflicts humans.
Original source: https://www.sciencedaily.com/releases/2019/02/190219111747.htm
